BNET Industries
Market Cap:$147.6B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
A Dividend-Stock Holiday Shopping List
-
Pfizer Whistleblower Named Year's Most Influential Person In Business Ethics
-
Week of Dec. 14, 2009: Company Notes: Sanofi Pasteur recalls H1N1 vaccine; Patheon consolidates Puerto...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two Existing Partnerships
-
Susan Kim: Menopause: Marketing Fear
-
Takeda, Pfizer To Co-Promote Actos Type 2 Diabetes Drug In China - Update
-
Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes
-
Pfizer Declares 1Q 2010 Cash Dividend
-
BRIEF: SEC probing insider-trading allegations
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Private security firms no longer able to provide police information checks
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
News & Analysis
Filter by
acquisition and pfizer inc. - All News and Analysis
Pfizer's Big Acquisition ... Is a Tiny Rights Deal With Cytos
BNET
- 2009-01-06
The world continues to fuliminate over the notion that Pfizer is poised to make a big deal. Could it be Amgen? Could it be Bristol-Myers Squibb? The speculation reached a new height of ridiculousness with this column in Today's Financial News, "Pfizer shouts its message to the...
Pharma Roundup: Pfizer's Acquisition Plans, Prasugrel's Big Day, and More
BNET
- 2009-01-05
Pfizer wants acquisitions, big and small. Prasugrel has a date with the FDA. New Year's blog feature bonanza. Farewell, Pharmalot. by John Maas
Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc
- 2008-06-10
NEW YORK -- Pfizer Inc (NYSE:PFE) today announced that it has completed the acquisition of all remaining outstanding shares of common stock of Encysive Pharmaceuticals Inc. (NASDAQ:ENCY) through a merger of Pfizer's wholly-owned subsidiary, Explorer Acquisition Corp., with and into Encysive. Encysive is now a wholly-owned subsidiary of Pfizer.
Stock Market Standouts List TheSUBWAYs New Small Cap Investor Forum Speak with Other Investors NASV Closes Second Acquisition & Increases Purchasing Power!
- 2008-01-09
M2 PRESSWIRE-9 January 2008-TheSubway.com: Stock Market Standouts List TheSUBWAYs New Small Cap Investor Forum Speak with Other Investors NASV Closes Second Acquisition & Increases Purchasing Power!C1994-2008 M2 COMMUNICATIONS LTD RDATE:09012008 ...
PharmEng Completes Acquisition of Pfizer Manufacturing Facility, Announces Closing of $20 Million Debt Financing and Full Payout of Amounts Owing to Shropshire S.a.r.L.
- 2007-12-31
PharmEng International Inc. (TSX VENTURE: PII), announced today that its subsidiary, Keata Pharma Inc., has completed its agreement with Pfizer Canada to acquire Pfizer's manufacturing facility in Arnprior, Ontario, including inventory. Concurrently, Keata has also entered into a supply agreement with Pfizer for the exclusive manufacture of certain Pfizer products...
PharmEng Completes Acquisition of Pfizer Manufacturing Facility, Announces Closing of $20 Million Debt Financing and Full Payout of Amounts Owing to Shropshire S.a.r.L.
- 2007-12-31
TORONTO, ONTARIO, Dec 31, 2007 Marketwire via COMTEX -- PharmEng International Inc. (TSX VENTURE:PII), announced today that its subsidiary, Keata Pharma Inc., has completed its agreement with Pfizer Canada to acquire Pfizer's manufacturing facility TORONTO, ONTARIO, Dec 31, 2007 Marketwire via COMTEX -- PharmEng International...
Pfizer Inc Clears Antitrust Review for Acquisition of All Outstanding Shares of Coley Pharmaceutical Group, Inc
- 2007-12-18
NEW YORK -- Pfizer (NYSE:PFE) announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 HSR Act has expired, and that it has received clearance from the Federal Cartel Office of Germany FCO, in each case in connection with its offer to purchase all of the...
Pharmacia Subsidiaries Reach $34.7 Million Settlement with DOJ; Resolve Allegations of Improper Activities Prior to Acquisition by Pfizer
- 2007-04-02
Pfizer Discovered and Promptly Reported Subsidiary's Off-Label Marketing of Genotropin to Justice Department, Other Agencies
Abraxis Bioscience Completes Acquisition of Manufacturing Complex from Pfizer
- 2007-02-14
State-of-the-Art Puerto Rico Facility Supplements Abraxis' Manufacturing Capabilities to Support Expansion of its Injectables Portfolio
PFIZER INC - Acquisition(s).
- 2007-02-01
Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline ...
Industry Transcripts by Seeking Alpha
-
Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
on Dec 18, 2009about NEOG
-
Schiff Nutrition International, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about WNI
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
Presented by American Express